Enhanced invasiveness in multidrug resistant leukemic cells is associated with overexpression of P-glycoprotein and cellular inhibitor of apoptosis protein

References

• Beesley AH, Cummings AJ, Freitas JR, The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure. Br J Haematol 2005;131:447–456.
   PubMed Web of Science ®Google Scholar
• Oh EJ, Kahng J, Kim Y, Expression of functional markers in acute lymphoblastic leukemia. Leuk Res 2003;27:903–908.
   PubMed Web of Science ®Google Scholar
• Miletti-Gonzalez KE, Chen S, Muthukumaran N, The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res 2005;65:6660–6667.
   PubMed Web of Science ®Google Scholar
• Liang Y, McDonnell S, Clynes M. Examining the relationship between cancer invasion/metastasis and drug resistance. Curr Cancer Drug Targets 2002;2:257–277.
   PubMed Web of Science ®Google Scholar
• Steinbach D, Legrand O. ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? Leukemia 2007;21:1172–1176.
   PubMed Web of Science ®Google Scholar
• Tallman MS, Gilliland DG, Rowe JM. Drug therapy for acute myeloid leukemia. Blood 2005;106:1154–1163.
   PubMed Web of Science ®Google Scholar
• Drain S, Catherwood MA, Alexander HD. Multidrug resistance in the chronic lymphoproliferative disorders. Leuk Lymphoma 2010;51:1793–1804.
   PubMed Web of Science ®Google Scholar
• Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48–58.
   PubMed Web of Science ®Google Scholar
• Quiney C, Billard C, Faussat AM, Salanoubat C, Kolb JP. Hyperforin inhibits P-gp and BCRP activities in chronic lymphocytic leukaemia cells and myeloid cells. Leuk Lymphoma 2007;48:1587–1599.
   PubMed Web of Science ®Google Scholar
• Hunter AM, LaCasse EC, Korneluk RG. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 2007;12:1543–1568.
   PubMed Web of Science ®Google Scholar
• Engels K, Knauer SK, Loibl S, NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Res 2008;68:5159–5166.
   PubMed Web of Science ®Google Scholar
• Vogler M, Giagkousiklidis S, Genze F, Gschwend JE, Debatin KM, Fulda S. Inhibition of clonogenic tumor growth: a novel function of Smac contributing to its antitumor activity. Oncogene 2005;24:7190–7202.
   Google Scholar
• Campone M, Vavasseur F, Le Cabellec MT, Meflah K, Vallette FM, Oliver L. Induction of chemoresistance in HL-60 cells concomitantly causes a resistance to apoptosis and the synthesis of P-glycoprotein. Leukemia 2001;15:1377–1387.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Hayashi H, Takagi K, Kondo T, Ueyama J, Wakusawa S. Protein kinase Cbeta isoform down-regulates the expression of MDR3 P-glycoprotein in human Chang liver cells. Biochim Biophys Acta 2006;1760:1552–1557.
   PubMed Web of Science ®Google Scholar
• Pan Q, Bao LW, Teknos TN, Merajver SD. Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma. Cancer Res 2006;66:9379–9384.
   PubMed Web of Science ®Google Scholar
• Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995;9:484–496.
   PubMed Web of Science ®Google Scholar
• Bao L, Gorin MA, Zhang M, Preclinical development of a bifunctional cancer cell homing, PKCepsilon inhibitory peptide for the treatment of head and neck cancer. Cancer Res 2009;69:5829–5834.
   PubMed Web of Science ®Google Scholar
• Aziz MH, Manoharan HT, Church DR, Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer. Cancer Res 2007;67:8828–8838.
   PubMed Web of Science ®Google Scholar
• Wheeler DL, Ness KJ, Oberley TD, Verma AK. Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice. Cancer Res 2003;63:6547–6555.
   PubMed Web of Science ®Google Scholar
• Lin HH, Chen JH, Chou FP, Wang CJ. Protocatechuic acid inhibits cancer cell metastasis involving the down-regulation of Ras/Akt/NF-kappaB pathway and MMP-2 production by targeting RhoB activation. Br J Pharmacol 2011;162:237–254.
   PubMed Web of Science ®Google Scholar
• Bourguignon LY, Spevak CC, Wong G, Xia W, Gilad E. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem 2009;284:26533–26546.
   PubMed Web of Science ®Google Scholar
• Lu Y, Pang T, Wang J, Down-regulation of P-glycoprotein expression by sustained intracellular acidification in K562/Dox cells. Biochem Biophys Res Commun 2008;377:441–446.
   PubMed Web of Science ®Google Scholar
• Fryknas M, Dhar S, Oberg F, STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines. Int J Cancer 2007;120:189–195.
   PubMed Web of Science ®Google Scholar
• Banning A, Kipp A, Schmitmeier S, Glutathione peroxidase 2 inhibits cyclooxygenase-2-mediated migration and invasion of HT-29 adenocarcinoma cells but supports their growth as tumors in nude mice. Cancer Res 2008;68:9746–9753.
   PubMed Web of Science ®Google Scholar
• Redondo-Munoz J, Ugarte-Berzal E, Garcia-Marco JA, Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells. Blood 2008;112:169–178.
   PubMed Web of Science ®Google Scholar
• Tong X, Zhang L, Hu M, The mechanism of chemokine receptor 9 internalization triggered by interleukin 2 and interleukin 4. Cell Mol Immunol 2009;6:181–189.
   PubMed Web of Science ®Google Scholar
• Nakagawa Y, Abe S, Kurata M, IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes. Am J Hematol 2006;81:824–831.
   PubMed Web of Science ®Google Scholar
• Che XF, Zheng CL, Owatari S, Overexpression of survivin in primary ATL cells and sodium arsenite induces apoptosis by down-regulating survivin expression in ATL cell lines. Blood 2006;107:4880–4887.
   PubMed Web of Science ®Google Scholar
• Khan S, Aspe JR, Asumen MG, Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br J Cancer 2009;100:1073–1086.
   PubMed Web of Science ®Google Scholar
• Mehrotra S, Languino LR, Raskett CM, Mercurio AM, Dohi T, Altieri DC. IAP regulation of metastasis. Cancer Cell 2010;17:53–64.
   PubMed Web of Science ®Google Scholar
• Shi YH, Ding WX, Zhou J, Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence. Hepatology 2008;48:497–507.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Eno ML, Ahn EH, Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer. Am J Clin Oncol 2010 Oct 1. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Gorin MA, Pan Q. Protein kinase C epsilon: an oncogene and emerging tumor biomarker. Mol Cancer 2009;8:9.
   PubMed Web of Science ®Google Scholar
• Reyland ME. Protein kinase C isoforms: multi-functional regulators of cell life and death. Front Biosci 2009;14:2386–2399.
   Google Scholar